Detalhe da pesquisa
1.
Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated COVID-19 vaccine followed by an mRNA vaccine in children aged 5-11 years.
J Med Virol
; 95(5): e28758, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37212319
2.
Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination.
J Infect Dis
; 226(8): 1372-1381, 2022 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35267040
3.
Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination.
J Med Virol
; 94(12): 5713-5722, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35924475
4.
Omicron BA.1, BA.2 and COVID-19 Booster Vaccination.
J Infect Dis
; 226(8): 1480-1481, 2022 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35481828
5.
Molecular characterization of serine protease inhibitor isoform 3, SmSPI, from Schistosoma mansoni.
Parasitol Res
; 115(8): 2981-94, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27083187
6.
Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3-4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination.
Heliyon
; 10(1): e23892, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38226248
7.
Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection.
Vaccines (Basel)
; 12(2)2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400163
8.
Neutralizing antibodies against Omicron BA.5 among children with infection alone, vaccination alone, and hybrid immunity.
Int J Infect Dis
; 134: 18-22, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207716
9.
Blockade-of-Binding Activities toward Envelope-Associated, Type-Specific Epitopes as a Correlative Marker for Dengue Virus-Neutralizing Antibody.
Microbiol Spectr
; 11(4): e0091823, 2023 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37409936
10.
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination.
Front Immunol
; 13: 1010835, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36268028
11.
Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination.
Diagnostics (Basel)
; 12(8)2022 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35892491
12.
COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron.
Vaccines (Basel)
; 10(3)2022 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35335023
13.
Persistence of immunity against Omicron BA.1 and BA.2 variants following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-dose AZD1222 vaccination.
Int J Infect Dis
; 122: 793-801, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35863731
14.
Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine.
Vaccine
; 40(39): 5657-5663, 2022 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031500